tiprankstipranks
Trending News
More News >
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
US Market

Inhibitor Therapeutics (INTI) Cash flow

Compare
30 Followers

Inhibitor Therapeutics Cash Flow

INTI's free cash flow for Q3 2025 was $-761.25K. For the 2025 fiscal year, INTI's free cash flow was decreased by $-532.74K and operating cash flow was $-761.25K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -3.23M$ -2.70M$ 11.74M$ -220.43K$ -825.36K
Investing Cash Flow
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 0.00$ -411.00K$ 180.00K$ 176.00K$ 96.60K
End Cash Position
$ 5.61M$ 8.84M$ 11.95M$ 30.63K$ 75.06K
Free Cash Flow
$ -3.23M$ -2.70M$ 11.74M$ -220.43K$ -825.36K
Currency in USD

Inhibitor Therapeutics Cash Flow